Minicule™, developed by Bowhead Health Inc., emerged from the need to uncover subtle biological patterns overlooked by traditional genetic research. Early studies focused on major discoveries like genes and proteins, yet vast omics datasets revealed micro-interactions—transient RNA expressions, rare epigenetic changes—that influence disease and cellular behavior. These 'minicules,' coined by computational biologists, are pivotal micro-units offering insights into disease pathways and therapeutic targets. Leveraging AI, bioinformatics, and multi-omics integration, Minicule empowers researchers worldwide to detect and interpret these critical micro-patterns, advancing precision medicine. Founded by a team of experts including Dr. Francisco Diaz-Mitoma, Minicule embodies the vision that groundbreaking progress lies in discerning the smallest biological signals for the biggest breakthroughs.